Characteristics of HCV positive patients in an Italian urban psychiatric unit

Clinical Practice and Epidemiology in Mental Health

Volumn 2, Issue , 2006, Pages

  Raja, Michele ^a   Azzoni, Antonella ^a   Pucci, Daniela ^b  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LITHIUM SALT; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; EDUCATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSTILITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; PSYCHIATRIC DEPARTMENT; RISK FACTOR; SCORING SYSTEM; SOCIAL CLASS; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; URBAN AREA; VIOLENCE;

EID: 33749635766     PISSN: 17450179     EISSN: None     Source Type: Journal    
DOI: 10.1186/1745-0179-2-26     Document Type: Article

References (49)

1. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP: Medical comorbidity in schizophrenia. Schizophr Bull 1996, 22:413-430.
2. Hewer W, Rossler W: Mortality of patients with functional psychiatric illnesses during inpatient treatment. Fortschr Neurol Psychiatr 1997, 65:171-181.
3. Zubenko GS, Marino LJ Jr, Sweet RA, Rifai AH, Mulsant BH, Pasternak RE: Medical comorbidity in elderly psychiatric inpatients. Biol Psychiatry 1997, 41:724-736.
4. Reeves RR, Torres RA: Exacerbation of psychosis by misinterpretation of physical symptoms. South Med J 2003, 96:702-704.
5. Farmer S: Medical problems of chronic psychiatric patients in a community support program. Hosp Comm Psychiatry 1987, 38:745-749.
6. Woo BK, Daly JW, Allen EC, Jeste DY, Sewell DD: Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. J Geriatr Psychiatry Neurol 2003, 16:121-125.
7. Black DW: Iowa record-linkage study: death rates in psychiatric patients. J Affect Disord 1998, 50:277-282.
8. Dembling B: Mental disorder as a contributing cause of death in the U.S. in 1992. Psychiatr Serv 1997, 48:45.
9. Dembling BP, Chen DT, Vachon L: Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv 1999, 50:1036-1042.
10. Felker B, Yazel JJ, Short D: Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv 1996, 47:1356-1363.
11. Harris EC, Barrablough B: Excess mortality of mental disorder. Br J Psychiatry 1998,.173:11-53.
12. Stroup TS, Gilmore JH, Jarskog LF: Management of medical illnesses in persons with schizophrenia. Psychiatr Ann 2000, 30:35-40.
13. Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS, Essock SM, Butterfield MI, Marsh BJ, Five-Site Health and Risk Study Research Committee: The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003, 54:827-835.
14. Desenclos JC: Epidemiology of hepatitis C. Rev Prat 2000, 50:1066-1070.
15. Memon MI, Memon MA: Hepatitis C: an epidemiological review. J Viral Hepat 2002, 9:84-100.
16. Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Cap P: The prevalence of hepatitis C in England and Wales. J Infect 2002, 45:219-226.
17. Williams I: Epidemiology of hepatitis C in the United States. Am J Med 1999, 107(6B)-2S-9S.
18. Davidson S, Judd F, Folley D, Hocking B, Thompson S, Hyland B: Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust N Z J Psychiatry 2001, 35:203-209.
19. El-Serag HB, Kunik M, Richardson P, Rabeneck L: Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002, 123:476-482.
20. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, Constantine NT: Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry 2003, 44:293-302.
21. Cividini A, Pistorio, A, Regazzetti A, Cerino A, Tinelli C, Mancuso A, Ribola M, Galli ML, Agnusdei A., Leone M, Silini E, Mondelli MU: Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol 1997, 27:455-463.
22. Nguyen HA, Miller Al, Dieperink E, Willenbring ML, Tetrick LL, Durfee JM, Ewing SL, Ho SB: Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterology 2002, 97:1813-1820.
23. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, Constantine NT, Wolford GL, Salyers MP: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001, 91:31-37.
24. Dinwiddie SH, Shicker L, Newman T: Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003, 160:172-174.
25. Morrison EF: A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hosp Commun Psychiatry 1992, 43:505-506.
26. Fernandez-Egea E, Gomez Gil E, Corbella Santoma B, Salamero Baro M, Blanch Andreu J, Vades Miyar M: Serological testing and prevalence of human immunodeficiency, hepatitis B and C viruses infections among acute psychiatric inpatients. Med Clin (Barc) 2002, 119:690-692.
27. Alter MJ, Kruszon-Moran D, Nainan OV, Mc Quillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Eng J Med 1999, 341:556-562.
28. Osher FC, Goldberg RW, McNary SW, Swartz MS, Essock SM, Butterfield MI, Rosenberg SD, the Five-Site Health and Risk Study Research Committee: Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatr Serv 2003, 54:842-847.
29. Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC, Goodman LA, Swanson JW, Bastian LA, Horner RD, Five-Site Health and Risk Study Research Committee: Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv 2003, 54:848-853.
30. Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V, Clotet B, Sabria M, Foz M: Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Br Med J 1990, 301:1130-1133.
31. Fiscus SA, Kelly WF, Battigelli DA, Weber DJ, Schoenbach VJ, Landis SE, Wilber JC, Van der Host CM: Hepatitis C virus seroprevalence in clients of sexually transmitted disease clinics in North Carolina. Sex Transm Dis 1994, 21:155-160.
32. Cilla G, Perez-Trallero E, Iturriza M, Arrizabalaga J, Iribarren JA: Possibility of heterosexual transmission of hepatitis C virus. Eur J Microbiol Infect Dis 1991, 10:533-534.
33. Salvaggio A, Conti M, Albano A, Pianetti A, Muggiasca ML, Re M, Selvaggio L: Sexual transmission of hepatitis C virus and HIV-1 infection in intravenous drug users. Eur J Epidemiology 1993, 9:279-284.
34. Sladden TJ, Hickey AR, Dunn TM, Beard Jr: Hepatitis C transmission on the north coast of New South Wales: explaining the unexplained. Med J Australia 1997, 166:290-293.
35. Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 1998, 47(RR-19):1-39.
36. Hershow RC, Kalish LA, Sha B, Till M, Cohen M: Hepatitis C virus infection in Chicago women with or at risk for HIV infection. Sex Transm Dis 1998, 25:527-532.
37. Ward H, Pallecaros A, Green A, Day S: Health issues associated with increasing use of "crack" cocairie among female sex workers in London. Sex Transm Infect 2000, 76:292-293.
38. Marsano LS, Pena LR: The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology 1998, 45:331-339.
39. Corrao G, Carle F, Lepore AR, Zepponi E, Galatola G, Di Orio F: Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: a case-controlled study. Eur J Epidemiol 1992, 9:634-639.
40. Stuyt EB: Hepatitis C in patients with co-occurring mental disorders and substance use disorders: is tobacco use a possible risk factor? Am J Addiction 2004, 13:46-52.
41. Dieperink E, Willenbring M, Ho SB: Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000, 157.867-876.
42. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N: Assessment of long term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000, 32:582-587.
43. Janssen HL, Brouwer JT, van der Mast RC, Schalm SW: Suicide associated with alfa-interferon therapy for chronic hepatitis. J Hepatol 1994, 21:241-243.
44. Bourat L, Larrey D, Michel H: Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases. Gastroenterol Clin Biol 1995, 19:1063.
45. Rifflet H, Vuillemin E, Oberti F, Duverger P, Laine P, Garre JB, Cales P: Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha. Gastroenterol Clin Biol 1998, 22:353-357.
46. Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H, Ueshima T, Maruyama K, Sakata I: Burns in a suicide attempt related to psychiatric side effects of interferon. Burns 1998, 24:581-583.
47. Pardelli R, Vivaldi I, Maccand O, Sani S, Menicagli V: Attempted suicide during interferon therapy: a case report and literature review. Infez Med 1998, 6:221-224.
48. Windemuth D, Bacharach-Buhles M, Hoffman K, Altmeyer P: Depression and suicidal intentions as a side effect of high dosage of interferon-alpha therapy: two cases. Hautarzt 1999, 50:266-269.
49. Kovacs A, Szomor A, Abraham I, Nagy F, Losonczy H: Orv Hetil 2002, 143:2183-2187.